ESR1 and breast carcinoma: In ER-positive patients treated with tamoxifen, the risk of breast cancer death was positively and strongly associated with Recurrence Score when analyzed as a continuous variable, when categorized into quartiles, or when categorized based on pre-specified cutoff points (Table 3).